Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Hansen, L.
1999.
Olanzapine in the treatment of anorexia nervosa.
British Journal of Psychiatry,
Vol. 175,
Issue. 6,
p.
592.
Green, Alan I
Patel, Jayendra K
Goisman, Robert M
Allison, David B
and
Blackburn, George
2000.
Weight gain from novel antipsychotic drugs: need for action.
General Hospital Psychiatry,
Vol. 22,
Issue. 4,
p.
224.
Wood, Martyn D.
Heidbreder, Christian
Reavill, Charles
Ashby, Charles R.
and
Middlemiss, Derek N.
2001.
5‐HT2C receptor antagonists: Potential in schizophrenia.
Drug Development Research,
Vol. 54,
Issue. 2,
p.
88.
Vera, Pedro L
and
Nadelhaft, Irving
2001.
Clozapine inhibits micturition parameters and the external urethral sphincter during cystometry in anesthetized rats.
Brain Research,
Vol. 901,
Issue. 1-2,
p.
219.
Vera, Pedro L.
and
Nadelhaft, Irving
2001.
Effects of the atypical neuroleptic clozapine on micturition parameters in anesthetized rats.
Neurourology and Urodynamics,
Vol. 20,
Issue. 5,
p.
623.
Kennedy, John S.
Bymaster, Frank P.
Schuh, Leslie
Calligaro, David O.
Nomikos, George
Felder, Christian C.
Bernauer, Mark
Kinon, Bruce J.
Baker, Robert W.
Hay, Donald
Roth, H. John
Dossenbach, Martin
Kaiser, Christopher
Beasley, Charles M.
Holcombe, John H.
Effron, Mark B.
and
Breier, Alan
2001.
A current review of olanzapine's safety in the geriatric patient: from pre-clinical pharmacology to clinical data.
International Journal of Geriatric Psychiatry,
Vol. 16,
Issue. S1,
p.
S33.
Dawe, Gavin S
Huff, Keith D
Vandergriff, Jim L
Sharp, Trevor
O’Neill, Michael J
and
Rasmussen, Kurt
2001.
Olanzapine activates the rat locus coeruleus: in vivo electrophysiology and c-Fos immunoreactivity.
Biological Psychiatry,
Vol. 50,
Issue. 7,
p.
510.
Wang, C
McInnis, J
Ross-Sanchez, M
Shinnick-Gallagher, P
Wiley, J.L
and
Johnson, K.M
2001.
Long-term behavioral and neurodegenerative effects of perinatal phencyclidine administration: implications for schizophrenia.
Neuroscience,
Vol. 107,
Issue. 4,
p.
535.
Tascedda, Fabio
Blom, Joan M.C
Brunello, Nicoletta
Zolin, Katia
Gennarelli, Massimo
Colzi, Anna
Bravi, Daniele
Carra, Serena
Racagni, Giorgio
and
Riva, Marco A
2001.
Modulation of glutamate receptors in response to the novel antipsychotic olanzapine in rats.
Biological Psychiatry,
Vol. 50,
Issue. 2,
p.
117.
Bymaster, Frank P
Falcone, Julie F
Bauzon, Delbert
Kennedy, John S
Schenck, Kathryn
DeLapp, Neil W
and
Cohen, Marlene L
2001.
Potent antagonism of 5-HT3 and 5-HT6 receptors by olanzapine.
European Journal of Pharmacology,
Vol. 430,
Issue. 2-3,
p.
341.
Goff, Donald C
Hennen, John
Lyoo, In Kyoon
Tsai, Guochuan
Wald, Lawrence L
Evins, A.Eden
Yurgelun-Todd, Deborah A
and
Renshaw, Perry F
2002.
Modulation of brain and serum glutamatergic concentrations following a switch from conventional neuroleptics to olanzapine.
Biological Psychiatry,
Vol. 51,
Issue. 6,
p.
493.
Chen, Long
and
Yang, Charles R.
2002.
Interaction of Dopamine D1 and NMDA Receptors Mediates Acute Clozapine Potentiation of Glutamate EPSPs in Rat Prefrontal Cortex.
Journal of Neurophysiology,
Vol. 87,
Issue. 5,
p.
2324.
Skogh, Elisabeth
Reis, Margareta
Dahl, Marja-Liisa
Lundmark, Jöns
and
Bengtsson, Finn
2002.
Therapeutic Drug Monitoring Data on Olanzapine and Its N-Demethyl Metabolite in the Naturalistic Clinical Setting.
Therapeutic Drug Monitoring,
Vol. 24,
Issue. 4,
p.
518.
Gonzalez-Pinto, Ana
Tohen, M.
Lalaguna, B.
Pérez-Heredia, J. L.
Fernandez-Corres, B.
Gutierrez, M.
and
Micó, J. A.
2002.
Treatment of Bipolar I Rapid Cycling Patients During Dysphoric Mania with Olanzapine.
Journal of Clinical Psychopharmacology,
Vol. 22,
Issue. 5,
p.
450.
Alvarez-Guerra, Miriam
Hameg, Ahcène
Bayle, Franck
Dib, Michel
and
Garay, Ricardo P
2002.
5-HT2A receptor antagonist properties of cyamemazine in rat and guinea pig smooth muscle.
European Journal of Pharmacology,
Vol. 454,
Issue. 2-3,
p.
235.
Poyurovsky, Michael
Pashinian, Artashes
Gil-Ad, Irit
Maayan, Rachel
Schneidman, Michael
Fuchs, Camil
and
Weizman, Abraham
2002.
Olanzapine-Induced Weight Gain in Patients With First-Episode Schizophrenia: A Double-Blind, Placebo-Controlled Study of Fluoxetine Addition.
American Journal of Psychiatry,
Vol. 159,
Issue. 6,
p.
1058.
Khojainova, Natalia
Santiago-Palma, Juan
Kornick, Craig
Breitbart, William
and
Gonzales, Gilbert R.
2002.
Olanzapine in the Management of Cancer Pain.
Journal of Pain and Symptom Management,
Vol. 23,
Issue. 4,
p.
346.
Ichikawa, Junji
Li, Zhu
Dai, Jin
and
Meltzer, Herbert Y
2002.
Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism.
Brain Research,
Vol. 956,
Issue. 2,
p.
349.
Campiani, Giuseppe
Butini, Stefania
Gemma, Sandra
Nacci, Vito
Fattorusso, Caterina
Catalanotti, Bruno
Giorgi, Gianluca
Cagnotto, Alfredo
Goegan, Mara
Mennini, Tiziana
Minetti, Patrizia
Di Cesare, M. Assunta
Mastroianni, Domenico
Scafetta, Nazzareno
Galletti, Bruno
Stasi, M. Antonietta
Castorina, Massimo
Pacifici, Licia
Ghirardi, Orlando
Tinti, Ornella
and
Carminati, Paolo
2002.
Pyrrolo[1,3]benzothiazepine-Based Atypical Antipsychotic Agents. Synthesis, Structure−Activity Relationship, Molecular Modeling, and Biological Studies.
Journal of Medicinal Chemistry,
Vol. 45,
Issue. 2,
p.
344.
van den Buuse, Maarten
2003.
Acute effects of antipsychotic drugs on cardiovascular responses to stress.
European Journal of Pharmacology,
Vol. 464,
Issue. 1,
p.
55.
eLetters
No eLetters have been published for this article.